Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-25-020661
Filing Date
2025-06-17
Accepted
2025-06-17 16:26:46
Documents
1
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 10456
  Complete submission text file 0001437749-25-020661.txt   12199
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Issuer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TIMBER PHARMACEUTICALS, INC. 900 E. HAMILTON AVENUE, SUITE 100 CAMPBELL CA 95008
Business Address
Bragg Kimberly (Reporting) CIK: 0001814159 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15911 | Film No.: 251053664